Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Technol Cancer Res Treat ; 14(6): 737-46, 2015 Dec.
Article in English | MEDLINE | ID: mdl-24988059

ABSTRACT

Recombinant Newcastle disease virus (rNDV) as antitumor agent has been shown to be effective for cancer therapy. And TNF-related apoptosis-inducing ligand (TRAIL) also has been demonstrated potentially cancer-therapeutic effects. In this study, we constructed TRAIL delivered by rNDV (rNDV-TRAIL) and investigated whether TRAIL would generate the potential synergistic therapeutic effects with rNDV for cancer therapy. In vitro experiments indicated that TRAIL expressed by rNDV demonstrated good biological activity. TRAIL significantly enhanced inducing apoptosis of rNDV in death receptor expression cancer cell lines. Experiments in malignant melanoma-bearing mice demonstrated that expression of TRAIL delivered by rNDV significantly inhibited the tumor growth and prolonged the survival of treated animals compared to control. In conclusion, oncolytic capacity of rNDV was augmented by TRAIL and the inherent anti-neoplastic properties of NDV were enhanced by the introduction of therapeutic TRAIL gene.


Subject(s)
Genetic Therapy/methods , Melanoma, Experimental/therapy , TNF-Related Apoptosis-Inducing Ligand/administration & dosage , Animals , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Genetic Vectors , Humans , Mice , Mice, Inbred C57BL , Newcastle disease virus , Polymerase Chain Reaction , Xenograft Model Antitumor Assays
2.
Yao Xue Xue Bao ; 49(7): 985-92, 2014 Jul.
Article in Chinese | MEDLINE | ID: mdl-25233628

ABSTRACT

To investigate the cell-killing effect and its possible mechanism of rClone30-hDR5 in combination with TRAIL on human hepatic carcinoma (HCC) cell line, first of all, recombinant plasmid pee12.4-hDR5 was introduced into HepG2 cells by liposome transfection. After five rounds of screening by flow cytometry, HepG2 cells expressing high levels of DR5 on cell surface were isolated. The cytotoxicity of TRAIL to selected cells was higher than that of TRAIL to HepG2 cells by MTT method (P < 0.01). The result suggested that the cloned hDR5 gene had biological activity. MTT assay showed that, rClone30- hDR5 in combination with TRAIL more efficiently inhibited the tumor growth of HepG2 cells compared to rClone30-hDR5 or TRAIL in vitro. The results of Annexin V-FITC/PI staining and Quantitative Real-time PCR indicated that rClone30-hDR5 in combination with TRAIL significantly increased the mRNA levels of caspase 3 and caspase 8, and induced the apoptosis of tumor cells. HepG2 cells were infected with rClone30-hDR5 or rClone30 at MOI of 1. The expression of hDR5 on tumor surface increased significantly by rClone30-hDR5 compared to that by rClone30, which contributed to the sensitivity to TRAIL. In conclusion, rClone30-hDR5 in combination with TRAIL has potential application value in cancer treatment.


Subject(s)
Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Receptors, TNF-Related Apoptosis-Inducing Ligand/pharmacology , TNF-Related Apoptosis-Inducing Ligand/pharmacology , Apoptosis , Caspase 3/metabolism , Caspase 8/metabolism , Drug Synergism , Hep G2 Cells , Humans , Real-Time Polymerase Chain Reaction , Transfection
3.
Yao Xue Xue Bao ; 49(3): 310-5, 2014 Mar.
Article in Chinese | MEDLINE | ID: mdl-24961100

ABSTRACT

In order to enhance the antitumor efficacy of recombinant Newcastle disease virus, rNDV-IL15 was rescued in this study. Recombinant plasmid prNDV-IL15 was constructed, and BHK21 cells were transfected with the recombinant plasmid. Finally, the recombinant Newcastle disease virus rNDV-IL15 was successfully rescued. The growth curves of these two recombinant viruses were determined. Murine melanoma B16F10 cells were infected with rNDV-IL15 at MOI of 0.1, and the expression level of IL15 in the supernatant was detected by ELISA. The antitumor efficacy of rNDV-IL15 and rNDV was compared in vitro and in vivo. Results showed that prNDV-IL15 was constructed and recombinant virus rNDV-IL15 was successfully rescued. The growth curve of rNDV-IL15 showed that the growth of rNDV-IL15 had not been changed after insertion of IL15 gene. Results showed that there was high level of IL15 expression in the supernatant of rNDV-IL5-infected B16F10 cells (1 044.3 +/- 27.7 ng x mL(-1)). rNDV-IL15 and rNDV significantly inhibited the growth of B16F10 cells in vitro in a time-dependent manner. However, there was no significant difference between them. In animal experiments, rNDV-IL15 efficiently suppressed tumor growth in vivo when compared with rNDV, and the difference was statistically significant. The results suggested that rNDV-IL15 is a more effective antitumor agent.


Subject(s)
Genetic Therapy , Interleukin-15/genetics , Melanoma, Experimental/pathology , Newcastle disease virus/genetics , Animals , Body Weight , Cell Line, Tumor , Cell Proliferation , Chick Embryo , Cytotoxicity, Immunologic , Female , Interleukin-15/metabolism , Melanoma, Experimental/therapy , Mice , Neoplasm Transplantation , Plasmids , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transfection , Tumor Burden
4.
Biotechnol Lett ; 36(3): 609-16, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24190480

ABSTRACT

We truncated the VP2 protein of infectious bursal disease virus into five fragments: V1-5. All fragments were displayed on the inner membrane of the Escherichia coli periplasm. After disruption of the outer membrane, spheroplasts that had anchored with the VP2 fragment were incubated with an anti-VP2 polyclonal antibody (pAb). Prey pairs were detected and quantitated by flow cytometry with V1, V3, V4 and V5 fragments reacting with the pAb. The antigenicity of all five fragments was analyzed, and our results indicated that epitopes were localized in V1, V3, V4 and V5, consistent with our flow cytometry analysis. Antigenicity analysis of purified VP2 fusion proteins using Western blots confirmed this. Our method provides a rapid, quantitative and simple strategy for identifying linear B cell epitopes.


Subject(s)
Antigens, Viral/immunology , Cell Surface Display Techniques/methods , Epitopes, B-Lymphocyte/immunology , Escherichia coli/metabolism , High-Throughput Screening Assays/methods , Infectious bursal disease virus/immunology , Viral Structural Proteins/immunology , Antigens, Viral/genetics , Escherichia coli/genetics , Flow Cytometry , Infectious bursal disease virus/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Viral Structural Proteins/genetics
5.
Asian Pac J Cancer Prev ; 14(12): 7489-96, 2013.
Article in English | MEDLINE | ID: mdl-24460323

ABSTRACT

This study was conducted to investigate enhancement of anti-tumor effects of the lentogenic Newcastle disease virus Clone30 strain (NDV rClone30) expressing cytosine deaminase (CD) gene against tumor cells and in murine groin tumor-bearing models. Cytotoxic effects of the rClone30-CD/5-FC on the HepG2 cell line were examined by an MTT method. Anti-tumor activity of rClone30-CD/5-FC was examined in H22 tumor-bearing mice. Compared to the rClone30-CD virus treatment alone, NDV rClone30-CD/5-FC at 0.1 and 1 MOIs exerted significant cytotoxic effects (P<0.05) on HepG2 cells. For treatment of H22 tumor-bearing mice, recombinant NDV was injected together with 5-FC given by either intra-tumor injection or tail vein injection. When 5-FC was administered by intra-tumor injection, survival for the rClone30-CD/5-FC-treated mice was 4/6 for 80 days period vs 1/6 , 0/6 and 0/6 for the mice treated with rClone30-CD, 5-FC and saline alone, respectively. When 5-FC was given by tail vein injection, survival for the rClone30-CD/5-FC-treated mice was 3/6 vs 2/6 , 0/6 and 0/6 for the mice treated with rClone30-CD, 5-FC or saline alone, respectively. In this study, NDV was used for the first time to deliver the suicide gene for cancer therapy. Incorporation of the CD gene in the lentogenic NDV genome together with 5-FC significantly enhances cell death of HepG2 tumor cells in vitro, decreases tumor volume and increases survival of H22 tumor-bearing mice in vivo.


Subject(s)
Antimetabolites/pharmacology , Cytosine Deaminase/genetics , Drug Synergism , Genetic Therapy , Genetic Vectors/therapeutic use , Liver Neoplasms, Experimental/therapy , Newcastle disease virus/genetics , Oncolytic Virotherapy , Adenoviridae/genetics , Animals , Combined Modality Therapy , Flucytosine/pharmacology , Fluorouracil/pharmacology , Humans , Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/mortality , Mice , Survival Rate , Tumor Cells, Cultured
6.
J Vet Med Educ ; 33(2): 238-43, 2006.
Article in English | MEDLINE | ID: mdl-16849304

ABSTRACT

Especially in developing countries, the profession of veterinary medicine is closely tied with agriculture and government economic development, the national structure of education, and national public health. Currently, the Chinese veterinary medical educational system and accreditation standards are distinctly different from those of some more developed countries, such as the United States, Japan, or the countries of the European Union. Chinese veterinary education is still closely based on traditional Chinese education approaches and standards, which has led to some deficiencies in the Chinese system. With the development of a stronger economy in China and the growing trend toward globalization, and particularly since China joined the World Trade Organization (WTO), some important questions about China's system of veterinary education are being raised: How can veterinary science develop more rapidly in China? How can it meet the needs of the growing Chinese society? How can China bring its veterinary medical practice more in line with that of other, more advanced countries? This article describes some of the realities of veterinary medical education in China, discusses several existing problems, and puts forward some ideas for possible reforms. It is hoped that by this means those outside China may gain insight into our veterinary education program and that this, in turn, will lead to helpful input from international educators and other professionals to help improve our programs.


Subject(s)
Curriculum , Education, Veterinary , China , Education, Veterinary/organization & administration , Education, Veterinary/standards , Humans , Models, Educational , Research , Teaching
7.
Virus Genes ; 30(3): 395-401, 2005 May.
Article in English | MEDLINE | ID: mdl-15830158

ABSTRACT

Genomic RNA was extracted from a Chinese isolate of porcine transmissible gastroenteritis virus (TGEV) designated TH-98. Employing RT-PCR technique to amplify ORF7 sequence of TGEV, which located at the 3' end of TGEV genome and is poorly understood functionally so far. A recombinant named pPROEX HTc-hp was constructed via inserting ORF7 gene into prokaryotic expression vector pPROEX HTc. The recombinant was sequenced and compared the DNA and its deduced amino acid (aa) sequences with that of some reference strains after restriction endonuclease and PCR analysis. The ORF7 gene named hp gene (Genbank accession number: AY337931) consists of 237 bp in length encoding a hydrophobic protein (HP) of 78 aa with a molecular weight of 9.1 kDa. The sequences of hp gene and Hp protein share 89%-97% and 87%-96% homologous identities compared with 11 TGEV reference strains derived from other regions or countries respectively, which revealed that there are significant variation within-strains, even though the ORF7 region is relatively conservative. In addition, a phylogenetic tree based on these ORF7 DNA sequences was generated, and the tree topology suggests that possible recombination events happened in the evolutionary history of TGEV.


Subject(s)
Open Reading Frames , Phylogeny , RNA, Viral/genetics , Transmissible gastroenteritis virus/genetics , Animals , Base Sequence , China , Gastroenteritis, Transmissible, of Swine/virology , Hydrophobic and Hydrophilic Interactions , Molecular Sequence Data , Molecular Weight , Polymerase Chain Reaction , Recombination, Genetic , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology , Swine , Transmissible gastroenteritis virus/classification , Transmissible gastroenteritis virus/isolation & purification , Viral Proteins/chemistry , Viral Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...